focus -WSS

focus

author：fashion 2025-09-06 04:51:22 - browse：855

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

“Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Winners, losers from Medicare’s list of drugs subject to price talks

WSS

How to make AI work for medicine

The real point of Kenneth Smith’s execution by nitrogen gas

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

AstraZeneca bets AAV gene therapy will still deliver the goods

Departing Stanford president retracts two papers

Apple Vision Pro: A first look at health apps on the new VR headset

leisure time

focus

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

The real point of Kenneth Smith’s execution by nitrogen gas

Guidelines to prevent youth baseball injuries need more muscle

Study finds new variant for Parkinson’s in African populations

At least 13 dead in Texas as scorching temps continue

Vertigo drug brings hope for rare neuron disorder, Niemann

Virginia high school admissions case could be legal follow

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Duchenne breakthrough therapy leaves behind pioneering families

Cognito secures funding to test medical device for Alzheimer's

knowledge

Diversity in medical illustrations gets boost from Chidiebere Ibe

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Winners, losers from Medicare’s list of drugs subject to price talks

General Catalyst, Summa Health deal will turn on physician buy

Winners, losers from Medicare’s list of drugs subject to price talks

Cybersecurity threat forces Lurie Children's to take systems offline

hotspot

focus

focus

focus